Westfield Capital Management
AMED

Westfield Capital Management’s Amedisys AMED Stock Holding History

Westfield Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-342,876
Closed -$25.2M – 229
2023
Q1 		$25.2M Buy
342,876
+13,271
+4% +$1.15M 0.18% 159
2022
Q4 		$27.5M Buy
329,605
+12,430
+4% +$1.12M 0.21% 145
2022
Q3 		$30.7M Sell
317,175
-3,831
-1% -$457K 0.24% 147
2022
Q2 		$33.7M Buy
321,006
+26,639
+9% +$3.4M 0.27% 134
2022
Q1 		$50.7M Sell
294,367
-4,092
-1% -$611K 0.33% 109
2021
Q4 		$48.3M Buy
298,459
+72,842
+32% +$11.7M 0.29% 115
2021
Q3 		$33.6M Buy
225,617
+61,136
+37% +$12.7M 0.2% 155
2021
Q2 		$40.3M Sell
164,481
-8,364
-5% -$2.19M 0.24% 140
2021
Q1 		$45.8M Sell
172,845
-12,215
-7% -$3.44M 0.28% 125
2020
Q4 		$54.3M Buy
185,060
+9,541
+5% +$2.45M 0.32% 108
2020
Q3 		$41.5M Sell
175,519
-133,209
-43% -$30.3M 0.27% 118
2020
Q2 		$61.3M Buy
308,728
+105,492
+52% +$19.7M 0.42% 82
2020
Q1 		$37.3M Buy
+203,236
New +$36.2M 0.33% 97

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Westfield Capital Management's AMED Position: Q2 2023 in Review

Westfield Capital Management sold out of Amedisys (AMED) in Q2 2023, closing a stake of 342,876 shares — an estimated $25.2M sold.

Westfield Capital Management first reported a position in AMED in Q1 2020 and held it in 13 quarters. The position peaked at $61.3M in Q2 2020. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Westfield Capital Management reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Westfield Capital Management sold 342,876 Amedisys shares in Q2 2023, an estimated $25.2M.
  • Westfield Capital Management first reported a position in Amedisys in Q1 2020 and held it in 13 quarters.
  • Westfield Capital Management's Amedisys position peaked at $61.3M in Q2 2020.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Westfield Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.